Related Experiment Video

Updated: Jul 13, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

Prevalence of subcortical vascular lesions and association with executive function in mild cognitive impairment

Stéphanie Bombois, Stéphanie Debette, Xavier Delbeuck

    Stroke
    |July 28, 2007
    PubMed
    Abstract

    Insights

    Subcortical hyperintensities (SH) are common in mild cognitive impairment (MCI). These brain changes, particularly in the periventricular and lobar white matter, are linked to executive dysfunction in MCI patients.

    Area of Science:

    • Neurology
    • Neuroimaging
    • Cognitive Science

    Background:

    • Subcortical hyperintensities (SH) prevalence and distribution in mild cognitive impairment (MCI) remain underexplored.
    • This study aimed to systematically evaluate SH in MCI patients and their association with cognitive function.

    Discussion:

    • SH are highly prevalent in MCI patients, regardless of MCI subtype.
    • Periventricular and lobar white matter hyperintensities are the most common locations of SH.
    • Executive dysfunction shows a significant independent association with the presence of SH.

    Key Insights:

    • High prevalence of SH (92.6%) observed in 170 MCI patients.
    • Periventricular (80.6%) and lobar white matter (83.5%) hyperintensities are the most frequent SH locations.
    • Executive dysfunction is independently associated with SH, periventricular hyperintensities, and white matter hyperintensities.

    Outlook:

    • Further research into the specific mechanisms linking SH to executive dysfunction in MCI is warranted.
    • Investigating the impact of SH on MCI progression and potential therapeutic interventions.
    • Exploring the role of SH as a potential biomarker for cognitive decline in aging populations.

    More Related Videos

    Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly12:50

    Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

    Published on: April 14, 2014

    Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains12:28

    Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

    Published on: June 3, 2020

    Related Concept Videos

    Dementia l: Introduction01:22

    Dementia l: Introduction

    Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
    Dementia01:30

    Dementia

    Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
    The progression of dementia is generally gradual.
    Alzheimer Disease l: Introduction01:29

    Alzheimer Disease l: Introduction

    Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
    Alzheimer Disease ll: Pathophysiology01:23

    Alzheimer Disease ll: Pathophysiology

    Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
    Alzheimer's Disease: Overview01:26

    Alzheimer's Disease: Overview

    Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
    The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
    Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

    Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

    Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...